Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity ...

Scientists have found a new antibiotic that could be over 100 times more effective in fighting ‘superbugs’ than existing ...

Revium Rx (formerly Revium Recovery Inc. (OTC: RVRC), a biopharmaceutical company developing advanced lipid-based therapeutics for infectious and oncologic diseases, today announced significant ...

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity against drug-resistant ...

Dietary habits linked to Parkinson’s risk: sweets, processed meats raise risk, fruit lowers them, Study finds Scientists have ...

A potent new antibiotic intermediate from Streptomyces coelicolor is 100 times stronger than methylenomycin A against drug-resistant bacteria.

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity ...

Antimicrobial resistance (AMR) is one of the world’s most urgent health challenges, with the WHO’s new report showing there are ‘too few antibacterials in the pipeline’. Most of the ‘low-hanging fruit ...

Through a joint R&D project with a research team led by Professor Kim Sung-hyun of the Department of Clinical Pathology at ...

A team of scientists discovered a hidden antibiotic 100 times stronger than existing drugs against deadly superbugs like MRSA. The molecule had been overlooked for decades in a familiar bacterium. It ...